<DOC>
	<DOCNO>NCT01061866</DOCNO>
	<brief_summary>The purpose study determine whether thalidomide effective refractory epilepsy treatment .</brief_summary>
	<brief_title>Thalidomide Low Threshold Epilepsy</brief_title>
	<detailed_description>Seven male patient chronic , refractory epilepsy include present study ; case antiepileptic treatment multiple antiepileptic drug unsuccessful reduce frequency intensity seizure . Patients select study male due high risk thalidomide teratogenicity pregnant woman ; besides drawback , thalidomide present fair tolerance profile human treat low dos . Informed consent obtain case patient legal guardian . The protocol approve committee research ethic . Treatment thalidomide 200 mg dosage twice daily administer twelve month period . Electroencephalograms obtain prior six month thalidomide therapy ; number intensity seizures individually record diary caregiver ( case patient 's mother ) ; sign neuropathy , frequent side-effect chronic thalidomide therapy , evaluate along treatment ; drowsiness sedation , also common side-effects , also record . Patients see week treatment period Epilepsy Clinic National Institute Neurology Neurosurgery Mexico . Once inform consent obtain , patient give seizure diary fill three month start treatment thalidomide . Comparisons frequency seizure make patient contrast three month previous begin thalidomide therapy twelve month drug trial . One patient ( case 6 ) withdraw trial seven month thalidomide therapy due sedation . Another patient ( case 7 ) withdraw trial 3 month treatment due exacerbation seizure narrate mother . The schedule antiepileptic therapy take patient three month prior thalidomide administration continue without modification along trial ; therefore , bias due change associate antiepileptic medication prevent patient serve control ; effect thalidomide frequency intensity seizure could reasonably evaluate . Thalidomide purchased National Institute Neurology Neurosurgery Mexico regular price pharmaceutical market . No pharmaceutical company participate form trial .</detailed_description>
	<mesh_term>Epilepsy</mesh_term>
	<mesh_term>Drug Resistant Epilepsy</mesh_term>
	<mesh_term>Thalidomide</mesh_term>
	<criteria>Refractory Epilepsy , male Females , peripheric neuropathy</criteria>
	<gender>Male</gender>
	<minimum_age>17 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>December 2009</verification_date>
	<keyword>Thalidomide</keyword>
	<keyword>Antiepileptic drug</keyword>
	<keyword>Refractory epilepsy</keyword>
	<keyword>Sedative drug</keyword>
</DOC>